Is Zevra Therapeutics Inc halal to invest in?

As of July 2026, Zevra Therapeutics Inc 1GDA.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Zevra Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Zevra Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Zevra Therapeutics Inc?

Muslim investors may consider investing in Zevra Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Zevra Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Zevra Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Zevra Therapeutics Inc updated?

The Shariah compliance status of Zevra Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Zevra Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Zevra Therapeutics Inc?

You can check the latest Shariah compliance status of Zevra Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Zevra Therapeutics Inc 1GDA.BE

Last Updated: Dec 29, 12:00 AM·BE

1GDA.BE Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Zevra Therapeutics Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Zevra Therapeutics Inc. Stock Analysis 1GDA.BE

Germany Health Care Small Cap Report: Q1, 2026

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The company is headquartered in Celebration, Florida and currently employs 59 full-time employees. The company went IPO on 2015-04-16. The company has a diverse portfolio of products and product candidates, which includes pre-clinical, clinical, and commercial stage assets. Its active commercial products and development assets include MIPLYFFA, OLPRUVA, Celiprolol, KP1077IH, KP1077N and AZSTARYS. MIPLYFFA (arimoclomol) is its approved therapy for the treatment of Niemann-Pick disease type C (NPC). OLPRUVA (sodium phenylbutyrate) is its treatment for the treatment of certain urea cycle disorders (UCDs). Celiprolol is its investigational clinical candidate for the treatment of Vascular Ehlers-Danlos Syndrome (VEDS). KP1077 is its product candidate intended for the treatment of rare sleep disorders. KP1077N is a clinical development candidate for narcolepsy. AZSTARYS is for the treatment of attention deficit and hyperactivity disorder.

Key Statistics of Zevra Therapeutics Inc (1GDA.BE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€7.40€7.65

Today's Open

€7.50

Volume

258.00

P/E Ratio (TTM)

8.95

Financial Metrics & Statements of Zevra Therapeutics Inc (1GDA.BE)

Super Investors Invested in Zevra Therapeutics Inc (1GDA.BE)

FAQ's for Zevra Therapeutics Inc (1GDA.BE)

As of July 2026, Zevra Therapeutics Inc 1GDA.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Zevra Therapeutics Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Zevra Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Zevra Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Zevra Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Zevra Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.